July 2021
New position in group Marc Vooijs working on new stem cell inhibitors in triple negative breast cancer. Click for more info and application

LOGO_ERC.png

July 2020

ERC PoC grant for team Marc Vooijs: INGSIGHT: Inhibition of Notch /g-secretase in hypoxic tumors. The team will focus on two new lead compounds targeting Notch signaling in tumors using a newly developed dual-specificity small molecule inhibitor and an inhibitor targeted PSEN2. read more.
 
For more info: contact marc.vooijs@maastrichtuniversity.nl 

December 2020: In collaboration with KU LeuvenKim Kampen (Co-PI) received a grant to study "Serine/glycine synthesis addiction in acute lymphoblastic leukemia and resulting therapeutic opportunities". 

STK.png